Tag: pharmaceuticals
-
MD Anderson, Investment Firm Create Cancer Start-Up
MD Anderson Cancer Center and health care investment enterprise Deerfield Management are starting a new company to develop treatments for cancer that tackle processes feeding tumor growth.
-
Scripps, Pfizer Collaborate on DNA-Coded Drug Discovery
Drug maker Pfizer Inc. is gaining access to advances in a synthetic chemistry technology developed by Scripps Research Institute that tags compounds with DNA identifiers.
-
Neurology Drug Signals Shown to Help Tooth Repair
Chemical signals from a drug designed to treat Alzheimer’s disease and other neurological disorders were shown in tests with mice to stimulate stem cells that repair teeth.
-
Sanofi Licensing Antibody for Autoimmune Diseases
The global drug company Sanofi is licensing a synthetic antibody to treat autoimmune disorders being developed by a spin-off enterprise from Dartmouth College.
-
Ionis Options Cardiac Drugs in $1.5 Billion Deal
Biotechnology company Ionis Pharmaceuticals is providing drug maker Novartis first access to two experimental drugs for controlling proteins that promote cholesterol and triglycerides, which contribute to heart disease.
-
Precision Health Tech Network Expands, Invests $400M
Digital Life Alliance, a consortium of enterprises applying advanced technologies to health and medicine that plans to offer personalized solutions, is expanding to 7 members, as well as iCarbonX, the company that founded the network.
-
Technique Uses Light to Activate Drugs in Blood Cells
A pharmacology lab developed a process that directs light waves at circulating blood cells to release drugs stored in those cells at precise times and locations.
-
Gene Expression Changes Found in Wound Healing Therapy
A clinical trial to reveal the mechanism of a cell therapy to treat venous skin ulcers found the therapy works by altering the gene expression activity of treated cells to resemble healthy tissue.
-
Biotech, Pharma Partner on Neuro Drug Discovery
A collaboration between a biotechnology enterprise tracking defective proteins and pharmaceutical company plans to discover new treatments for neurodegenerative disorders.
-
Antibody Trials Stopped After Deaths Reported
The U.S. Food and Drug Administration halted early-stage clinical trials of a monoclonal antibody drug for leukemia after four deaths occurred from liver toxicity.